In conclusion, we demonstrated that microglial Calhm2 is involved in microglia-mediated neuroinflammation and the pathogenesis of PD by modulating the EFhd2-STAT3 pathway in microglia, which provides potential therapeutic targets for microglia-mediated neuroinflammation-related diseases. The gene discussed is CALHM2; the disease is Parkinson disease.